» Articles » PMID: 33823213

Impact of the New Definition of Pulmonary Hypertension According to World Symposium of Pulmonary Hypertension 2018 on Diagnosis of Post-capillary Pulmonary Hypertension

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2021 Apr 6
PMID 33823213
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The World Symposium on Pulmonary Hypertension (WSPH) in 2018 recommended new definitions of pulmonary hypertension (PH). We investigated the impact of the updated definition on prevalence of PH due to left heart disease (PH-LHD).

Methods: The data of right heart catheterizations in patients with suspected PH-LHD between January 2008 and July 2015 was retrospectively analyzed applying different definitions. The number of patients diagnosed by the updated WSPH hemodynamic criteria of a mean pulmonary artery pressure (mPAP) > 20 mmHg was compared to the number of patients using mPAP ≥ 25 mmHg. The differentiation between patients with isolated post-capillary (Ipc) and combined post-capillary and pre-capillary (Cpc) PH was analyzed comparing the ESC/ERS guidelines, the recommendation of Cologne Consensus Conference (CCC) and WSPH.

Results: Of the 726 patients with a suspected PH, 58 patients met the diagnostic criteria of the ESC/ERS guidelines for PH-LHD with 32.8% Ipc-cases, 34.4% Cpc-PH-cases and 32.8% unclassifiable cases. Overall, 58 patients were diagnosed by the CCC criteria, with 34.5% classified as Cpc-PH and 65.5% as Icp-PH. Using the criteria of WSPH, the number of PH-LHD rose by one patient. According to the new definition, 64.4% of the patients were classified as Cpc-PH and had a significantly higher right to left atrial area (RA/LA) ratio than Ipc-PH patients.

Conclusion: Applying the new recommendation, the number of diagnosed patients with PH-LHD increases marginally. There is, however, a relevant shift in the number of Cpc-PH cases. An elevated RA/LA ratio might help to identify patients for invasive diagnostic work-up.

Citing Articles

Impact of the 2022 pulmonary hypertension definition on haemodynamic classification and mortality in patients with aortic stenosis undergoing valve replacement.

Maeder M, Weber L, Pohle S, Chronis J, Baty F, Rigger J Eur Heart J Open. 2024; 4(3):oeae037.

PMID: 38812478 PMC: 11135639. DOI: 10.1093/ehjopen/oeae037.


Endobronchial ultrasound: A novel screening test for pulmonary hypertension prior to major pulmonary surgery.

Deboever N, Eapen G, Casal R, Durand J, Eisenberg M, Feldman H JTCVS Tech. 2024; 23:146-153.

PMID: 38352000 PMC: 10859667. DOI: 10.1016/j.xjtc.2023.10.030.


Diagnosing post-capillary hypertension in patients with left heart disease: impact of new guidelines.

Guder G, Reiter T, Fette G, Hundertmark M, Frantz S, Morbach C Clin Res Cardiol. 2023; .

PMID: 37668664 DOI: 10.1007/s00392-023-02290-5.


Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs.

Jin Q, Chen D, Zhang X, Zhang F, Zhong D, Lin D Pharmaceutics. 2023; 15(6).

PMID: 37376028 PMC: 10305538. DOI: 10.3390/pharmaceutics15061579.


Measurement of Pulmonary Artery Wave Reflection Before and After Mitral Valvuloplasty in Canine Patients With Pulmonary Hypertension Caused by Myxomatous Mitral Valve Disease.

Yoshida T, Shimada K, Hamabe L, Uchide T, Tanaka R, Matsuura K Front Vet Sci. 2021; 8:773035.

PMID: 34926644 PMC: 8674487. DOI: 10.3389/fvets.2021.773035.